Support Needs and Preferences of Family Caregivers of Lung Cancer Patients

NCT00967083 | Completed

• 1 other identifier: 09-104
• Study Type: observational
• Target: 53
• Locations: 1 country
• Sites: 2

Brief Summary

This study is being done to learn what the needs are in relation to the family members. Some family members seek counseling; others do not. The institution wants to try to understand why and wants to see if they can improve our support services for family members.

Conditions

Lung Cancer

Keywords

Quality of Life; Questionnaires; Interviews; family members; care givers; 09-104

Outcome Measures

Primary Outcomes (1)

• Assess psychosocial info & practical needs of prim family caregivers of lung cancer pts.Mental health (anxiety & depression)& behavioral health needs(smoking cessation,alcohol abuse)will be assessed b/c these 2 types of needs are strongly correlate

  13 to 16 weeks

Secondary Outcomes (3)

• To assess psychosocial and practical barriers to psychosocial support service use among primary family caregivers of lung cancer patients

  13 to 16 weeks

• To assess family caregivers' preferences (preferred topics, modality, provider, timing) regarding psychosocial support interventions.

  13 to 16 weeks

• To gather descriptive information regarding participant flow for planning future intervention studies.

  13 to 16 weeks

Study Arms (1)

family caregivers of lung cancer patients

In this 2-year pilot study, we plan to screen family caregivers of lung cancer patients within 4 to 6 weeks after the a new visit to the thoracic clinic. We will screen spouses, adult children, and other family members using the HAD-18 to determine their level of anxiety and depressive symptoms at enrollment.

Behavioral: Questionnaires/Interviews

Interventions

Questionnaires/Interviews BEHAVIORAL

Baseline assessment of distressed caregivers within 4-6 weeks a new visit to the thoracic clinic. Three-month follow-up assessment of caregivers. Qualitative phone interviews with a subsample of 30 caregivers within 3 weeks of follow-up.

family caregivers of lung cancer patients

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients whose family caregivers may be eligible for this study will be identified by a member of the patient's treatment team, the protocol investigator, or research team at Memorial Sloan-Kettering Cancer Center (MSKCC) or Queens Cancer Center (QCC).

You may qualify if:

• Primary family caregiver identified by a patient who is approximately within 4 to 6 weeks of a new visit to a thoracic clinic and receiving cancer care at Memorial Sloan-Kettering Cancer Center or Queens Cancer Center
• Caregiver is at least 18 years of age.
• Caregiver has adequate English fluency for completion of data collection. The surveys were designed and validated in English and are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the surveys.
• Clinically meaningful distress defined as a score of 8 or greater on the Anxiety or Depression subscale of the HADS (see Bjelland et al., 2002; Zigmond \& Snaith, 1983).

You may not qualify if:

• Patients or caregivers exhibiting significant psychiatric or cognitive impairment (dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation
• Patient has lung cancer recurrence
• Currently participating in a psychosocial intervention trial

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead
• Queens Cancer Center of Queens Hospital: collaborator
• Michigan State University: collaborator
• National Cancer Institute (NCI): collaborator
• Indiana University: collaborator

Study Sites (2)

Queens Cancer Center of Queens Hospital

Jamaica, New York, 11432, United States

Location

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Memorial Sloan-Kettering Cancer Center

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Surveys and Questionnaires; Interviews as Topic

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Jamie Ostroff, PhD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 26, 2009
• First Posted: August 27, 2009
• Study Start: August 1, 2009
• Primary Completion: December 1, 2014
• Study Completion: December 1, 2014
• Last Updated: December 11, 2014

Record last verified: 2014-12

Locations

US (2)